PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 21 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Phenolic compounds from flowers significantly inhibited cell proliferation even at low concentrations (25-100 μg/mL) in vitro [PMID:22051932]
Ethanol extracts of T. pratensis demonstrated antileukemic properties by inducing apoptosis in vitro [PMID:22568040]
Evidence summary
PubMed sources
- 1.PMID: 23430325 (2013) — An assessment of karyotype restructuring in the neoallotetraploid Tragopogon miscellus (Asteraceae). · Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology
- 2.PMID: 39155917 (2024) — The complete chloroplast genome sequence and phylogenetic analysis of Tragopogon pratensis L. (Asteraceae). · Mitochondrial DNA. Part B, Resources
- 3.PMID: 22051932 (2011) — Phenolic compounds from Allium schoenoprasum, Tragopogon pratensis and Rumex acetosa and their antiproliferative effects. · Molecules (Basel, Switzerland)
- 4.PMID: 25938765 (2015) — Morphologic and Aerodynamic Considerations Regarding the Plumed Seeds of Tragopogon pratensis and Their Implications for Seed Dispersal. · PloS one
- 5.PMID: 28707708